Related Experiment Video
Updated: Aug 23, 2026

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells
Published on: January 18, 2019
Rubella immunization in human immunodeficiency virus type 1-infected children: cause for concern in vaccination
Mylena Lima1, Regina Célia De Menezes Succi, Amélia M Nunes Dos Santos
1Department of Pediatrics, Federal University of Sao Paulo, Sao Paulo, Brazil.
Insights
Human immunodeficiency virus (HIV) infection impacts rubella vaccine response in children. Those with advanced HIV infection show a poorer antibody response compared to those with preserved immunity.
Area of Science:
- Pediatrics
- Immunology
- Infectious Diseases
Background:
- Human immunodeficiency virus (HIV) infection can unexpectedly increase the number of children susceptible to rubella.
- Assessing rubella immunization response in HIV-infected children is crucial for public health.
Purpose of the Study:
- To evaluate the rubella vaccine immune response in HIV-infected children.
- To compare the response in HIV-infected children with seroreverted and healthy controls.
Main Methods:
- The study involved 15 HIV-infected children, 20 seroreverted children, and 18 healthy controls.
- Rubella IgG antibody titers were measured before and 3 months after vaccination.
- All HIV-infected children received highly active antiretroviral therapy from infancy.
Main Results:
- HIV-infected children in advanced immunologic categories (2/3) had significantly lower rubella antibody titers compared to controls.
- Antibody levels correlated positively with CD4 T cell counts and negatively with HIV viral load.
- Only 62% of HIV-infected children in categories 2/3 achieved protective antibody levels, versus 94-100% in other groups.
Conclusions:
- HIV-infected children with preserved immune function respond well to the rubella vaccine.
- Children with advanced HIV infection exhibit a diminished response to rubella immunization.
- These findings highlight the importance of immune status in vaccine efficacy for HIV-infected children.
Background:
HIV infection can have important although sometimes unexpected consequences, such as contributing to enlargement of the pool of rubella-susceptible children.
Methods:
At the Federal University of São Paulo, Brazil, we assessed response to rubella immunization at 15 months of age in 15 human immunodeficiency virus type 1 (HIV)-infected children, 20 seroreverted children (SR) and 18 healthy control children born to HIV-seronegative mothers (CON). Blood samples were collected before and 3 months after vaccination. All HIV-infected children had started highly active antiretroviral therapy during their first 6 months of life. Serum samples were tested with a rubella IgG enzyme-linked immunosorbent assay kit.
Results:
HIV children in immunologic categories 2/3 had lower rubella antibody titers (geometric mean, 33 IU/mL) than those from CON (125 IU/mL) and SR group (236 IU/mL) (Tukey, P = 0.01). Antibody values after vaccination were positively associated with CD4 T cell numbers and negatively associated with HIV viral load assessed immediately before vaccination. The percentage of children with protective antibodies after vaccination (above 10.0 IU/mL) was also significantly different among groups (Fisher's exact test, P = 0.013): CON, 94%; SR, 100%; HIV category 1, 100%; HIV category 2/3, 62%.
Conclusions:
HIV-infected children with a preserved immune system at measles-mumps-rubella immunization can have a good response to rubella vaccine. In contrast, those in more advanced categories for HIV infection respond poorly.
More Related Videos
Related Concept Videos
Respiratory Syncytial Virus Disease
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Chickenpox
Cytomegalovirus Disease

